{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/71331856"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Gemcitabine and cisplatin doses should be withheld or reduced by 50% for severe (grade 3 or 4) nonhematologic toxicity other than alopecia or nausea and vomiting." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "leiomyosarcoma.info" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/56780571"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/71331856" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/362726466"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/71331856"] } } }
